A drug under investigation as a treatment for a rare genetic disorder that causes abnormally high triglyceride levels in the blood has received orphan-drug designation from the Food and Drug Administration.
The Food and Drug Administration announced Friday the approval of Waltham, Mass.-based Thermo Fisher’s QMS Everolimus Immunoassay, a test that monitors the blood for levels of Novartis’ drug Zortress (everolimus).
The National Advertising Division of the Council of Better Business Bureaus on Wednesday announced that Pharmavite is able to support advertising claims for the company’s NatureMade GreatMind dietary supplement, pursuant to NAD’s ongoing monitoring of advertising for dietary supplements.
After months of speculation, BJ's Wholesale Club early Thursday morning confirmed the company has decided to explore and evaluate strategic alternatives. Coupled with that announcement was a positive sales story for the year.
LiceGuard on Monday announced the launch of its Robi Comb product, a noninvasive electronic lice comb powered by a single AA battery that detects and destroys lice on contact simply by combing it through dry hair.
Advanced Vision Research on Monday announced results from a pilot trial published in the journal Cornea that demonstrated a reduction in dry-eye symptoms and an increase in tear volume and tear flow for those patients taking TheraTears Nutrition, an optimized blend of omega-3 oils.